Press Releases
Marken Launches COVID-19 Test Kit Production Unit
Marken announced it has begun producing COVID-19 test kits in its Miami facility as an extension of its global supply chain solutions offering. The completed kits are currently shipping and will be distributed throughout the U.S. and Canada.
As one...
Press Releases
Thermo Fisher Scientific to Co-develop a Global Companion Diagnostic for Low-grade Glioma with Agios Pharmaceuticals
Thermo Fisher Scientific announced that it has expanded its strategic partnership with Agios Pharmaceuticals by adding the co-development of a second companion diagnostic (CDx) for oncology to their existing agreement. The CDx will leverage the Oncomine Precision Assay, which...
Press Releases
Sharp Clinical Launches Direct-to-Patient Service With New Partnerships
Sharp Clinical Services, part of UDG Healthcare and a leading provider of global clinical supply services, has signed a central pharmacy partnership deal and developed a holistic patient support programme with its sister company, Ashfield.
The company has signed a...
Press Releases
AstraZeneca takes next steps towards broad and equitable access to Oxford University’s COVID-19 vaccine
AstraZeneca has taken the next steps in its commitment to broad and equitable global access to the University of Oxford’s COVID-19 vaccine, following landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the...
Drug Research
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland announced that they have entered into a new, significant partnering agreement to accelerate the development, manufacture and distribution of a COVID-19 vaccine candidate which has been...
Press Releases
FDA Approves Merck’s RECARBRIO for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
Merck, known as MSD outside the United States and Canada, announced that the U.S. FDA has approved a supplemental New Drug Application (sNDA) for RECARBRIO for the treatment of patients 18 years of age and older with hospital-acquired bacterial...
Press Releases
AI to deliver next evolution of drug manufacturing and supply chain efficiency
In the absence of ‘in person’ meetings, access to deep dive pharma insights are not on hold, and later this month experts will discuss how AI is rapidly evolving supply chain dynamics in a ground-breaking Pharmapack Europe webinar (June...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read